122 related articles for article (PubMed ID: 22712408)
21. [Advances in Parvovirus Non-structural Protein NS1 Induced Apoptosis].
Tu M; Liu F; Chen S; Wang M; Cheng A
Bing Du Xue Bao; 2015 Nov; 31(6):679-84. PubMed ID: 26951015
[TBL] [Abstract][Full Text] [Related]
22. Evolution of canine parvovirus involved loss and gain of feline host range.
Truyen U; Evermann JF; Vieler E; Parrish CR
Virology; 1996 Jan; 215(2):186-9. PubMed ID: 8560765
[TBL] [Abstract][Full Text] [Related]
23. Peptide nucleic acid-based (PNA) array for the antigenic discrimination of canine parvovirus.
An DJ; Jeong W; Jeoung HY; Lee MH; Park JY; Lim JA; Park BK
Res Vet Sci; 2012 Aug; 93(1):515-9. PubMed ID: 21764414
[TBL] [Abstract][Full Text] [Related]
24. [Adenovirus-mediated canine interferon-gamma expression and its antiviral activity against canine parvovirus].
Zhang K; Jin H; Zhong F; Li X; Neng C; Chen H; Li W; Wen J
Wei Sheng Wu Xue Bao; 2012 Nov; 52(11):1400-7. PubMed ID: 23383512
[TBL] [Abstract][Full Text] [Related]
25. Sequence analysis of VP2 gene of canine parvovirus isolated from domestic dogs in Japan in 1999 and 2000.
Doki M; Fujita K; Miura R; Yoneda M; Ishikawa Y; Taneno A; Kai C
Comp Immunol Microbiol Infect Dis; 2006 Jul; 29(4):199-206. PubMed ID: 16870254
[TBL] [Abstract][Full Text] [Related]
26. [Distribution of antigen types of canine parvovirus in Switzerland, Austria and Germany].
Truyen U; Steinel A; Bruckner L; Lutz H; Möstl K
Schweiz Arch Tierheilkd; 2000 Mar; 142(3):115-9. PubMed ID: 10748710
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a canine parvovirus strain isolated from an adult dog.
Cavalli A; Bozzo G; Decaro N; Tinelli A; Aliberti A; Buonavoglia D
New Microbiol; 2001 Jul; 24(3):239-42. PubMed ID: 11497080
[TBL] [Abstract][Full Text] [Related]
28. Characterization and evaluation of apoptotic potential of double gene construct pVIVO.VP3.NS1.
Saxena S; Desai GS; Kumar GR; Sahoo AP; Santra L; Singh LV
Indian J Exp Biol; 2015 May; 53(5):249-55. PubMed ID: 26040021
[TBL] [Abstract][Full Text] [Related]
29. Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus.
Horiuchi M; Yamaguchi Y; Gojobori T; Mochizuki M; Nagasawa H; Toyoda Y; Ishiguro N; Shinagawa M
Virology; 1998 Sep; 249(2):440-52. PubMed ID: 9791034
[TBL] [Abstract][Full Text] [Related]
30. First detection of canine parvovirus type 2c in South America.
Pérez R; Francia L; Romero V; Maya L; López I; Hernández M
Vet Microbiol; 2007 Sep; 124(1-2):147-52. PubMed ID: 17531408
[TBL] [Abstract][Full Text] [Related]
31. Analysis of VP2 gene sequences of canine parvovirus isolates in India.
Chinchkar SR; Mohana Subramanian B; Hanumantha Rao N; Rangarajan PN; Thiagarajan D; Srinivasan VA
Arch Virol; 2006 Sep; 151(9):1881-7. PubMed ID: 16583153
[TBL] [Abstract][Full Text] [Related]
32. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
33. Detection of canine parvovirus type 2c by a commercially available in-house rapid test.
Decaro N; Desario C; Beall MJ; Cavalli A; Campolo M; Dimarco AA; Amorisco F; Colaianni ML; Buonavoglia C
Vet J; 2010 Jun; 184(3):373-5. PubMed ID: 19410488
[TBL] [Abstract][Full Text] [Related]
34. New approaches for the molecular characterization of canine parvovirus type 2 strains.
Decaro N; Elia G; Campolo M; Desario C; Lucente MS; Bellacicco AL; Buonavoglia C
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):316-9. PubMed ID: 16316391
[TBL] [Abstract][Full Text] [Related]
35. A real-time PCR assay for rapid detection and quantitation of canine parvovirus type 2 in the feces of dogs.
Decaro N; Elia G; Martella V; Desario C; Campolo M; Trani LD; Tarsitano E; Tempesta M; Buonavoglia C
Vet Microbiol; 2005 Jan; 105(1):19-28. PubMed ID: 15607080
[TBL] [Abstract][Full Text] [Related]
36. Antigenic analysis of canine parvovirus strains isolated in Italy.
Buonavoglia D; Cavalli A; Pratelli A; Martella V; Greco G; Tempesta M; Buonavoglia C
New Microbiol; 2000 Jan; 23(1):93-6. PubMed ID: 10946411
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of canine parvovirus strains in Argentina: Detection of the pathogenic variant CPV2c in vaccinated dogs.
Calderon MG; Mattion N; Bucafusco D; Fogel F; Remorini P; La Torre J
J Virol Methods; 2009 Aug; 159(2):141-5. PubMed ID: 19490967
[TBL] [Abstract][Full Text] [Related]
38. Soluble form of canine transferrin receptor inhibits canine parvovirus infection in vitro and in vivo.
Wen J; Pan S; Liang S; Zhong Z; He Y; Lin H; Li W; Wang L; Li X; Zhong F
Biomed Res Int; 2013; 2013():172479. PubMed ID: 24089666
[TBL] [Abstract][Full Text] [Related]
39. [Canine parvovirus: recent knowledge of the origin and development of a viral pathogen].
Truyen U
Tierarztl Prax; 1994 Dec; 22(6):579-84. PubMed ID: 7716757
[TBL] [Abstract][Full Text] [Related]
40. Surveillance activity for canine parvovirus in Italy.
Martella V; Decaro N; Elia G; Buonavoglia C
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):312-5. PubMed ID: 16316390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
